Acceleration of oxime-induced reactivation of organophosphate-inhibited fetal bovine serum acetylcholinesterase by monoquaternary and bisquaternary ligands.

Reactivation of organophosphate (OP)-inhibited acetylcholinesterase (AChE) by oximes is the primary reason for their effectiveness in the treatment of OP poisoning. Reactivation is reported to accelerate by quaternary ligands such as decamethonium, which is devoid of nucleophilicity. The mechanism of this enhancement is not known. To better understand the acceleration phenomenon, we examined ligand modulations of oxime-induced reactivation of methylphosphonylated AChE using 7-(methylethoxyphosphinyloxy)-1-methylquinolinium iodide and fetal bovine serum AChE. Edrophonium, decamethonium, and propidium, three quaternary AChE ligands of different types, were tested as potential accelerators. Experiments were carried out with both soluble enzyme preparation and AChE conjugated to polyurethane. Kinetic measurements with oximes 2-[hydroxyiminomethyl]-1-methylpyridinium chloride, 1,1'-trimethylene bis-(4-hydroxyimino methyl)-pyridinium dibromide, and 1, 1'-[oxybis-methylene)bis[4-(hydroxyimino)methyl]pyridiniu um dichloride showed that in the presence of 50 microM edrophonium, the reactivation rate constants increased 3.3-12.0-fold; 200 microM decamethonium produced a 1.6-3.0-fold enhancement of reactivation rate constants by the same oximes. Reactivation of the inhibited enzyme by 1-(2-hydroxyiminomethyl-1-pyridinium)-1-(4-carboxy-aminopyridinium )-d imethyl ether hydrochloride, 1-(2-hydroxyiminomethyl-1-pyridinium)-1-(3-carboxy-aminopyridinium )-d imethyl ether hydrochloride, and 1-[[[4-(aminocarbonyl)pyridino]methoxy]methyl]-2, 4, -bis(hydroxyimino)methyl pyridinium dichloride was not affected by either ligand. Propidium slowed the reactivation of 7-(methylethoxyphosphinyloxy)-1- methylquinolinium iodide-inhibited AChE by all oximes. Results suggest that the accelerator site may reside inside the catalytic gorge rather than at its entrance and acceleration may be due to the prevention of reinhibition of the regenerated enzyme by the putative product, the phosphonylated oxime. In addition to the nucleophilic property of the oximate anion, some of the reactivators may carry an accelerating determinant, as characterized with respect to edrophonium and decamethonium. Results offer possible explanations for the superiority of 1-(2-hydroxyiminomethyl-1-pyridinium)-1-(4-carboxy-aminopyridinium )-d imethyl ether hydrochloride over other oximes in the reactivation of specific AChE-OP conjugates.

[1]  Y. Ashani,et al.  Combined effect of organophosphorus hydrolase and oxime on the reactivation rate of diethylphosphoryl-acetylcholinesterase conjugates. , 1998, Biochemical pharmacology.

[2]  B. P. Doctor,et al.  Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. , 1997, Biochemistry.

[3]  M. Froment,et al.  Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase. , 1997, The Biochemical journal.

[4]  A. Shafferman,et al.  Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives. , 1996, Molecular pharmacology.

[5]  N. Ariel,et al.  Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite. , 1995, Biochemistry.

[6]  I. Enyedy,et al.  Origins and diversity of the aging reaction in phosphonate adducts of serine hydrolase enzymes: what characteristics of the active site do they probe? , 1995, Biochemistry.

[7]  B. No̸rgaard-Pedersen,et al.  Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants. , 1995, Brain research. Molecular brain research.

[8]  I. Tsigelny,et al.  Amino Acid Residues Controlling Reactivation of Organophosphonyl Conjugates of Acetylcholinesterase by Mono- and Bisquaternary Oximes (*) , 1995, The Journal of Biological Chemistry.

[9]  N. Ariel,et al.  Contribution of Aromatic Moieties of Tyrosine 133 and of the Anionic Subsite Tryptophan 86 to Catalytic Efficiency and Allosteric Modulation of Acetylcholinesterase (*) , 1995, The Journal of Biological Chemistry.

[10]  Y. Ashani,et al.  Huperzine A as a pretreatment candidate drug against nerve agent toxicity. , 1994, Life sciences.

[11]  J. Sussman,et al.  Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Galli,et al.  Acetylcholinesterase protection and the anti-diisopropylfluorophosphate efficacy of E2020. , 1994, European journal of pharmacology.

[13]  N. Ariel,et al.  Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. , 1994, The Journal of biological chemistry.

[14]  P. Chiang,et al.  Monoclonal antibody AE-2 modulates carbamate and organophosphate inhibition of fetal bovine serum acetylcholinesterase. , 1993, Molecular pharmacology.

[15]  P. Taylor,et al.  The role of glutamate-199 in the aging of cholinesterase. , 1993, Biochemical and biophysical research communications.

[16]  J. Sussman,et al.  Relationship between sequence conservation and three‐dimensional structure in a large family of esterases, lipases, and related proteins , 1993, Protein science : a publication of the Protein Society.

[17]  M. Sentjurc,et al.  A contribution to the mechanism of action of SAD-128. , 1990, Biochemical pharmacology.

[18]  Y. Ashani,et al.  Differences in conformational stability between native and phosphorylated acetylcholinesterase as evidenced by a monoclonal antibody. , 1990, Biochemistry.

[19]  L. Szinicz,et al.  Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. , 1988, Biochemical pharmacology.

[20]  H. Berman,et al.  Kinetic, equilibrium, and spectroscopic studies on dealkylation ("aging") of alkyl organophosphonyl acetylcholinesterase. Electrostatic control of enzyme topography. , 1986, The Journal of biological chemistry.

[21]  H. Berman,et al.  Kinetic, equilibrium and spectroscopic studies on cation association at the active center of acetylcholinesterase: topographic distinction between trimethyl and trimethylammonium sites. , 1986, Biochimica et biophysica acta.

[22]  B. P. Doctor,et al.  A simplified procedure for the purification of large quantities of fetal bovine serum acetylcholinesterase. , 1986, Life sciences.

[23]  Y. Ashani,et al.  Synthesis and in vitro properties of a powerful quaternary methylphosphonate inhibitor of acetylcholinesterase. A new marker in blood-brain barrier research. , 1986, Biochemical pharmacology.

[24]  R. Scott,et al.  In vitro studies on the reactivation by oximes of phosphylated acetylcholinesterase--II. On the formation of O,O-diethyl phosphorylated AChE and O-ethyl methylphosphonylated AChE and their reactivation by PS2. , 1986, Biochemical pharmacology.

[25]  R. Scott,et al.  In vitro studies on the reactivation by oximes of phosphylated acetylcholinesterase--I. On the reactions of P2S with various organophosphates and the properties of the resultant phosphylated oximes. , 1986, Biochemical pharmacology.

[26]  L. D. de Jong,et al.  Reactivation of acetylcholinesterase inhibited by 1,2,2'-trimethylpropyl methylphosphonofluoridate (soman) with HI-6 and related oximes. , 1980, Biochemical pharmacology.

[27]  C. Broomfield,et al.  Effects of 1,1'-oxydimethylene bis-(4-tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman- and sarin-inhibited cholinesterase by oximes. , 1978, Biochemical pharmacology.

[28]  P Taylor,et al.  Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding. , 1975, Biochemistry.

[29]  K. Schoene.  Reaktivierung von O,O-diäthylphosphoryl-acetylcholinesterase: Reaktivierungs-rephosphorylierungs-gleichgewicht , 1972 .

[30]  K. Schoene.  [Reactivation of O,O-diethylphosphoryl-acetylcholinesterase. Reactivation rephosphorylation equilibrium]. , 1972, Biochemical pharmacology.

[31]  R. Kitz,et al.  Acceleration of the rate of reaction of methanesulfonyl fluoride and acetylcholinesterase by substituted ammonium ions. , 1963, The Journal of biological chemistry.

[32]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[33]  P. Taylor,et al.  Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives. , 1991, Molecular pharmacology.

[34]  A. Gray.  Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents. , 1984, Drug metabolism reviews.

[35]  P. Taylor,et al.  Interaction between bisquaternary ammonium ligands and acetylcholinesterase: complex formation studied by fluorescence quenching. , 1974, Molecular pharmacology.

[36]  J. Lamb,et al.  Letter to the editorFormation of potent inhibitors of AChE by reaction of pyridinaldoximes with isopropyl methylphosphonofluoridate (GB) , 1959 .

[37]  J. Gergely,et al.  Participation of a dialyzable cofactor in the relaxing factor system of muscle. I. Studies with single glycerinated fibres. , 1959, Biochimica et biophysica acta.